Abstract
Background
The efficacy of midazolam as premedication in children for providing pre-operative sedation and reducing parental separation anxiety has been well established. Many studies have compared the effectiveness and medication acceptance of midazolam via oral and intranasal routes. In this study, we have compared the ease of administration of oral midazolam syrup and intranasal midazolam spray as premedication, administered by parents to children.
Methods
Ninety children were randomly allocated into one of the two groups: group N received nasal midazolam spray 0.2 mg/kg and group O received oral midazolam syrup 0.5 mg/kg administered by the parent. The parent recorded ease of administration score and facial hedonic score. The observer recorded modified medication acceptance score. Vitals and sedation scores were assessed at specific intervals. Thirty minutes after drug administration the child was separated from the parent, and parental separation anxiety score was recorded. Mask acceptance score was recorded after application of mask upon arrival in the OT.
Results
Oral midazolam syrup was found to have better ease of administration than intranasal midazolam spray as felt by the parent. Medication acceptance was better for oral midazolam. Both the groups had similar sedation scores at 15 and 30 min. Children in the oral group had a better reduction in parental separation anxiety at 30 min after drug administration and better mask acceptance than the nasal group.
Conclusion
Oral midazolam syrup is easier for parents to administer and has better medication acceptance in children when compared to intranasal midazolam spray.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Pacifici GM. Clinical pharmacology of midazolam in neonates and children: effect of disease—a review. Int J Pediatr. 2014;2014:309342.
McCann ME, Kain ZN. The management of pre-operative anxiety in children: an update. Anesth Analg. 2001;93(1):98–105.
Wilton NC, Leigh J, Rosen DR, Pandit UA. Pre-anesthetic sedation of preschool children using intranasal midazolam. Anesthesiology. 1988;69(6):972–5.
Feld LH, Negus JB, White PF. Oral midazolam pre-anesthetic medication in pediatric outpatients. Anesthesiology. 1990;73(5):831–4.
Kupietzky A, Houpt MI. Midazolam: a review of its use for conscious sedation of children. Pediatr Dent. 1993;15(4):237–41.
Karl HW, Rosenberger JL, Larach MG, Ruffle JM. Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes. Anesthesiology. 1993;78(5):885–91.
Coté CJ, Cohen IT, Suresh S, Rabb M, Rose JB, Weldon BC, Davis PJ, Bikhazi GB, Karl HW, Hummer KA, Hannallah RS, Khoo KC, Collins P. A comparison of three doses of a commercially prepared oral midazolam syrup in children. Anesth Analg. 2002;94(1):37–43 (table of contents).
Bhakta P, Ghosh B, Roy M, Mukherjee G. Evaluation of intranasal midazolam for preanaesthetic sedation in paediatric patients. Indian J Anaesth. 2007;51(2):111–120.
Coelho B, Ambareesha M, Alex S. Comparison of intranasal and oral midazolam as premedicant drug in preschool children. J Anaesthesiol Clin Pharmacol. 2008;24(3):333–6.
Verma RK, Paswan A, De A, Gupta S. Premedication with midazolam nasal spray: an alternative to oral midazolam in children. Anesthesiol Pain Med. 2012;1(4):248–51.
Cox RG, Nemish U, Ewen A, Crowe M-J. Evidence-based clinical update: does premedication with oral midazolam lead to improved behavioural outcomes in children? Can J Anaesth J Can Anesth. 2006;53(12):1213–9.
Kuppuswamy B. Manual of socioeconomic status (urban). 1st ed. Delhi: Manasayan; 1981. p. 66–72.
Yildirim SV, Guc BU, Bozdogan N, Tokel K. Oral versus intranasal midazolam premedication for infants during echocardiographic study. Adv Ther. 2006;23(5):719–24.
Thompson A, Reader S, Field E, Shephard A. Open-label taste-testing study to evaluate the acceptability of both strawberry-flavored and orange-flavored amylmetacresol/2,4-dichlorobenzyl alcohol throat lozenges in healthy children. Drugs RD. 2013;13(2):101–7.
Kraus DM, Stohlmeyer LA, Hannon PR. Infant acceptance and effectiveness of a new oral liquid medication delivery system. Am J Health Syst Pharm AJHP Off J Am Soc Health Syst Pharm. 1999;56(11):1094–101.
Griffith N, Howell S, Mason DG. Intranasal midazolam for premedication of children undergoing day-case anaesthesia: comparison of two delivery systems with assessment of intra-observer variability. Br J Anaesth. 1998;81(6):865–9.
Raval DL. Comparative study of oral and trans nasal midazolam as a sedative premedication in paediatric patients. J Clin Exp Res. 2014;2(3):158–62.
Klein EJ, Brown JC, Kobayashi A, Osincup D, Seidel K. A randomized clinical trial comparing oral, aerosolized intranasal, and aerosolized buccal midazolam. Ann Emerg Med. 2011;58(4):323–9.
Malinovsky JM, Populaire C, Cozian A, Lepage JY, Lejus C, Pinaud M. Premedication with midazolam in children. Effect of intranasal, rectal and oral routes on plasma midazolam concentrations. Anaesthesia. 1995;50(4):351–4.
Walbergh EJ, Wills RJ, Eckhert J. Plasma concentrations of midazolam in children following intranasal administration. Anesthesiology. 1991;74(2):233–5.
Malinovsky JM, Cozian A, Lepage JY, Mussini JM, Pinaud M, Souron R. Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology. 1991;75(1):91–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
About this article
Cite this article
Manoj, M., Satya prakash, M.V.S., Swaminathan, S. et al. Comparison of ease of administration of intranasal midazolam spray and oral midazolam syrup by parents as premedication to children undergoing elective surgery. J Anesth 31, 351–357 (2017). https://doi.org/10.1007/s00540-017-2330-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-017-2330-6